Dr Stuart Kendrick Professor David Jones
| GLIMMER: A Randomized Phase 2b Dose-Ranging Trial of Linerixibat in Primary Biliary Cholangitis Patients With Pruritus | 2023 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| Autotaxin, bile acid profile and effect of ileal bile acid transporter inhibition in primary biliary cholangitis patients with pruritus | 2019 |
|
Dr Vinod Hegade Dr Holly Fisher Dr Stuart Kendrick Professor David Jones
| Pruritus Is Common and Undertreated in Patients With Primary Biliary Cholangitis in the United Kingdom | 2019 |
|
Dr Jess Dyson Dr Lin Lee Wong Dr Theophile Bigirumurame Dr Stuart Kendrick Professor David Jones et al. | Inequity of care provision and outcome disparity in autoimmune hepatitis in the United Kingdom | 2018 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| Effect of ileal bile acid transporter inhibitor GSK2330672 on pruritus in primary biliary cholangitis: a double-blind, randomised, placebo-controlled, crossover, phase 2a study | 2017 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| A Phase 2 Randomised Crossover Trial of Ileal Bile Acid Transporter Inhibitor GSK2330672 in Patients with Primary Biliary Cholangitis and Symptoms of Pruritus | 2016 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| BAT117213: Ileal bile acid transporter (IBAT) inhibition as a treatment for pruritus in primary biliary cirrhosis: study protocol for a randomised controlled trial | 2016 |
|
Dr Lin Lee Wong Dr Stuart Kendrick Professor David Jones Dr Jess Dyson
| UK-AIH - Highlighting the need for standardization of treatment in autoimmune hepatitis | 2016 |
|
Dr Jess Dyson Dr Jeremy Palmer Dr Lin Lee Wong Dr Stuart Kendrick Professor David Jones et al. | Understanding the importance of pro- and anti-inflammatory cytokines in autoimmune hepatitis | 2016 |
|
Dr Lin Lee Wong Dr Stuart Kendrick Dr Jess Dyson Professor David Jones
| Understanding the unmet need in Autoimmune Hepatitis - The United Kingdom AIH Study (UK-AIH) | 2016 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| A study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of repeat doses of GSK2330672 administration in subjects with primary biliary cirrhosis and symptoms of pruritus | 2015 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| Itch and liver: management in primary care | 2015 |
|
Dr Caroline Wilson Dr Lindsay Murphy Jack Leslie Dr Stuart Kendrick Jeremy French et al. | Ubiquitin C-terminal hydrolase 1: A novel functional marker for liver myofibroblasts and a therapeutic target in chronic liver disease | 2015 |
|
Dr Vinod Hegade Dr Stuart Kendrick Professor David Jones
| Patient Experience and Characteristics of Cholestatic Pruritus in the UK-PBC Research Cohort | 2014 |
|